lifelancer
The Scientific Director, Bioconjugation Development will set the long‑term scientific vision for next‑generation antibody‑drug, antibody‑peptide, and antibody‑oligonucleotide conjugates, driving innovation in conjugation technologies, linker‑payload design, and manufacturability. This senior leader will guide cross‑functional teams, manage external partnerships, and influence enterprise‑level strategy to advance bioconjugate programs from discovery through commercialization.
Headquarters
London, England, United Kingdom
Company Size
51-200 employees
Founded
2020
Lifelancer is an AI-powered global talent marketplace that connects life sciences, pharma, biotech, healthtech and IT organizations with freelance, remote and contract specialists. The platform helps employers hire talent and agencies and supports remote hiring and payroll, while listing scientific, consulting and IT roles for candidates. Using AI-driven matching and domain-focused search, Lifelancer streamlines sourcing for R&D, clinical, regulatory and technical functions across the life sciences and technology sectors.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for lifelancer.
5% above the average for this role
Scientific Director, Bioconjugation Development
Neurocrine Biosciences
Associate Director, ADC platform in Oncology Drug Discovery
Novartis
Associate Director, ADC platform in Oncology Drug Discovery
Novartis
Scientist II, BioConjugation
Astellas
Large Molecule Scientific Lead
Cogent Scientific
Sr. Scientist, Protein and Antibody Bioconjugation
Neurocrine Biosciences